{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T16:29:24Z","timestamp":1759940964668},"reference-count":54,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,12,1]],"date-time":"2007-12-01T00:00:00Z","timestamp":1196467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropeptides"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1016\/j.npep.2007.09.003","type":"journal-article","created":{"date-parts":[[2007,11,26]],"date-time":"2007-11-26T21:27:33Z","timestamp":1196112453000},"page":"411-419","source":"Crossref","is-referenced-by-count":12,"title":["Endogenous kappa opioids mediate the action of brain angiotensin II to increase blood pressure"],"prefix":"10.1016","volume":"41","author":[{"given":"Simon W.","family":"Rabkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.npep.2007.09.003_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1146\/annurev.ne.07.030184.001255","article-title":"Endogenous opioids: biology and function","volume":"7","author":"Akil","year":"1984","journal-title":"Annual Review of Neuroscience"},{"key":"10.1016\/j.npep.2007.09.003_bib3","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/j.1476-5381.1995.tb14976.x","article-title":"Regional haemodynamic effects of mu-, delta-, and kappa-opioid agonists microinjected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats","volume":"115","author":"Bachelard","year":"1995","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.npep.2007.09.003_bib4","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1113\/jphysiol.1985.sp015829","article-title":"Selective cardiovascular and neuroendocrine effects of a kappa-opioid agonist in the nucleus tractus solitarii of rats","volume":"367","author":"Carter","year":"1985","journal-title":"Journal of Physiology"},{"key":"10.1016\/j.npep.2007.09.003_bib5","first-page":"R193","article-title":"Angiotensin II attenuates baroreflexes at nucleus tractus solitarius of rats","volume":"250","author":"Castro","year":"1986","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.npep.2007.09.003_bib6","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1023\/A:1025080314925","article-title":"Functional organization of brain pathways subserving the baroreceptor reflex: studies in conscious animals using immediate early gene expression","volume":"23","author":"Dampney","year":"2003","journal-title":"Cellular and Molecular Neurobiology"},{"key":"10.1016\/j.npep.2007.09.003_bib7","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1152\/physrev.2001.81.4.1599","article-title":"The hypothalamus and hypertension","volume":"81","author":"de Wardener","year":"2000","journal-title":"Physiological Reviews"},{"key":"10.1016\/j.npep.2007.09.003_bib8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1440-1681.2002.03659.x","article-title":"Angiotensin peptides as neurotransmitters\/neuromodulators in the dorsomedial medulla","volume":"29","author":"Diz","year":"2002","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1016\/j.npep.2007.09.003_bib9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1124\/jpet.104.076828","article-title":"Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioidU-50488H[(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus","volume":"312","author":"Gottlieb","year":"2005","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.npep.2007.09.003_bib10","first-page":"H80","article-title":"Angiotensin II attenuates baroreflex control of heart rate and sympathetic activity","volume":"246","author":"Gu","year":"1984","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.npep.2007.09.003_bib11","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.peptides.2005.10.012","article-title":"The cardiovascular responses to mu opioid agonist and antagonist in conscious normal and obese rats","volume":"27","author":"Hill-Pryor","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2007.09.003_bib12","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0006-8993(76)90405-4","article-title":"Regional study of cerebroventricle sensitive sites to angiotensin II","volume":"110","author":"Hoffman","year":"1976","journal-title":"Brain Research"},{"key":"10.1016\/j.npep.2007.09.003_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/0024-3205(88)90525-5","article-title":"Attentuation by naloxone of the pressor effects of angiotensin II in conscious cynomolgus monkeys","volume":"43","author":"Kirby","year":"1988","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2007.09.003_bib14","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1365-201X.1996.d01-723.x","article-title":"Endogenous opioid mechanisms in hypothalamic blood flow autoregulation during haemorrhagic hypotension and angiotensin-induced acute hypertension in cats","volume":"157","author":"Komjati","year":"1996","journal-title":"Acta Physiologica Scandinavica"},{"key":"10.1016\/j.npep.2007.09.003_bib15","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0014-2999(83)90558-7","article-title":"Effect of naloxone on baroreflex, sympathetic tone and blood pressure in the cat","volume":"90","author":"Koyama","year":"1983","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.npep.2007.09.003_bib16","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0014-2999(91)90575-B","article-title":"Chronic kappa-opioid receptor antagonism delays the rise in blood pressure in spontaneously hypertensive rats","volume":"200","author":"Kraft","year":"1991","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.npep.2007.09.003_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.npep.2006.05.001","article-title":"Role of limbic peptidergic circuits in regulation of arterial pressure, relevant to development of essential hypertension","volume":"40","author":"Ku","year":"2006","journal-title":"Neuropeptides"},{"issue":"Suppl I","key":"10.1016\/j.npep.2007.09.003_bib18","first-page":"140","article-title":"Brain angiotensin: pathways and pharmacology","volume":"77","author":"Lang","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.npep.2007.09.003_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.RES.47.2.286","article-title":"Mechanisms by which angiotensin II affects the heart of conscious sheep","volume":"47","author":"Lee","year":"1980","journal-title":"Circ. Res."},{"key":"10.1016\/j.npep.2007.09.003_bib20","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1042\/bj2950629","article-title":"Molecular cloning and expression of a rat kappa opioid receptor","volume":"295","author":"Li","year":"1993","journal-title":"Biochem. J."},{"key":"10.1016\/j.npep.2007.09.003_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1113\/jphysiol.1979.sp012915","article-title":"Inhibition by angiotensin II of baroreceptor-evoked activity in vagal efferent nerves in the dog","volume":"294","author":"Lumbers","year":"1979","journal-title":"J. Physiol. (Lond)"},{"key":"10.1016\/j.npep.2007.09.003_bib22","first-page":"154","article-title":"Enkephalin catabolism in vitro and in vivo","volume":"16","author":"Meek","year":"1977","journal-title":"Neurochemistry"},{"key":"10.1016\/j.npep.2007.09.003_bib23","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1073\/pnas.81.5.1575","article-title":"Autoradiographic localization of angiotensin II receptors in rat brain.","volume":"81","author":"Mendelsohn","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.npep.2007.09.003_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.npep.2003.09.003","article-title":"Cardiovascular and behavioural effects induced by naloxone-precipitated morphine withdrawal in rat: characterization with tachykinin antagonists","volume":"37","author":"Michaud","year":"2003","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2007.09.003_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0014-5793(93)80923-I","article-title":"cDNA cloning and pharmacological characterization of an opioid receptor with high affinities for kappa-subtype-selective ligands","volume":"330","author":"Nishi","year":"1993","journal-title":"FEBS Lett."},{"key":"10.1016\/j.npep.2007.09.003_bib26","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1440-1681.2005.04200.x","article-title":"Hypothesis: set-points and long-term control of arterial pressure. A theoretical argument for a long-term arterial pressure control system in the brain rather than the kidney","volume":"32","author":"Osborn","year":"2005","journal-title":"Clinical & Experimental Pharmacology & Physiology"},{"key":"10.1016\/j.npep.2007.09.003_bib27","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1177\/1073858404264678","article-title":"Brain angiotensin II and synaptic transmission","volume":"10","author":"Pan","year":"2004","journal-title":"Neuroscientist"},{"issue":"Suppl 1","key":"10.1016\/j.npep.2007.09.003_bib28","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neuropharm.2004.07.004","article-title":"Multiple opiate receptors: deja vu all over again","volume":"47","author":"Pasternak","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.npep.2007.09.003_bib29","first-page":"735","article-title":"Cardiovascular and respiratory effects of mu-, delta- and kappa-opiate agonists microinjected into the anterior hypothalamic brain area of awake rats","volume":"225","author":"Pfeiffer","year":"1983","journal-title":"Journal of Pharmacology & Experimental Therapeutics"},{"key":"10.1016\/j.npep.2007.09.003_bib30","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev.ph.49.030187.002213","article-title":"Functions of angiotensin II in the central nervous system","volume":"49","author":"Phillips","year":"1987","journal-title":"Ann. Rev. Physiol."},{"key":"10.1016\/j.npep.2007.09.003_bib31","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/cvr\/23.10.904","article-title":"Cardiorespiratory effects of d-Ala-2-Me-Phe-4-Met-(O)-o1 enkephalin in the third ventricle and in anterior hypothalamic and paraventricular areas of the rat","volume":"23","author":"Rabkin","year":"1980","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.npep.2007.09.003_bib32","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0024-3205(91)90566-T","article-title":"Angiotensin II in the brain suppresses epinephrine-induced cardiac arrhythmias through CNS opioid mechanisms","volume":"49","author":"Rabkin","year":"1991","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2007.09.003_bib33","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1440-1681.1991.tb01475.x","article-title":"Diltiazem and verapamil lower blood pressure in the unanaesthetized rat through CNS mechanisms involving endogenous opioids","volume":"18","author":"Rabkin","year":"1991","journal-title":"Clinical & Experimental Pharmacology & Physiology"},{"key":"10.1016\/j.npep.2007.09.003_bib34","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/0024-3205(94)00605-9","article-title":"Comparative effects of central administration of naloxone and clonidine on the blood pressure and heart rate response to anterior and posterior hypothalamic stimulation","volume":"54","author":"Rabkin","year":"1994","journal-title":"Life Sciences"},{"key":"10.1016\/j.npep.2007.09.003_bib35","first-page":"405","article-title":"Cardiovascular effects of centrally administered opioid peptides considering their opioid receptor agonist properties","volume":"2","author":"Rabkin","year":"1987","journal-title":"J. Appl. Cardiol."},{"key":"10.1016\/j.npep.2007.09.003_bib36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S0196-9781(03)00122-0","article-title":"Cardiovascular responses to central administration of mu and kappa opioid receptor agonist and antagonist in normal rats","volume":"24","author":"Rao","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.npep.2007.09.003_bib37","first-page":"F333","article-title":"Actions of angiotensin on the brain: mechanisms and physiologic role.","volume":"246","author":"Reid","year":"1984","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.npep.2007.09.003_bib38","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1152\/physrev.1987.67.3.725","article-title":"Peptides and central neural regulation of the circulation.","volume":"67","author":"Rettog","year":"1987","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.npep.2007.09.003_bib39","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0006-8993(86)90835-8","article-title":"Cardiovascular effects of microinjections of angiotensin II into the nucleus tractus solidarius.","volume":"364","author":"Rettog","year":"1986","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2007.09.003_bib40","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0024-3205(80)90107-1","article-title":"Bremazocine: a potent long-acting opiate k-agonist.","volume":"27","author":"Romer","year":"1980","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2007.09.003_bib41","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/0024-3205(79)90403-X","article-title":"Mini-review on the specificity of naloxone as an opiate antagonist.","volume":"25","author":"Sawynek","year":"1979","journal-title":"Life Sci."},{"key":"10.1016\/j.npep.2007.09.003_bib42","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3109\/10641969909068667","article-title":"Depressor effect of kappa opioid agonist on hypertension induced by isolation in the rat.","volume":"21","author":"Shen","year":"1999","journal-title":"Clinical & Experimental Hypertension (New York)"},{"key":"10.1016\/j.npep.2007.09.003_bib43","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0006-8993(85)91392-7","article-title":"Angiotensin II receptor localization in the canine CNS.","volume":"326","author":"Speth","year":"1985","journal-title":"Brain Res."},{"key":"10.1016\/j.npep.2007.09.003_bib44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0165-6147(92)90110-R","article-title":"Angiotensin receptor subtypes in the brain.","volume":"13","author":"Steckelings","year":"1992","journal-title":"Trends in Pharmacological Sciences"},{"key":"10.1016\/j.npep.2007.09.003_bib45","first-page":"619","article-title":"Endogenous opioid peptide inhibition of the central actions of angiotensin.","volume":"217","author":"Summy-Long","year":"1981","journal-title":"J. Pharmacol. Exper. Therapy"},{"key":"10.1016\/j.npep.2007.09.003_bib46","doi-asserted-by":"crossref","first-page":"267S","DOI":"10.1042\/cs059267s","article-title":"The role of endogenous opiates in the area postrema pressor pathway.","volume":"59","author":"Szilagyi","year":"1980","journal-title":"Clin. Sci."},{"key":"10.1016\/j.npep.2007.09.003_bib47","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1161\/01.RES.56.4.563","article-title":"Differential effects of central angiotensin II and substance P on sympathetic nerve activity in conscious rats.","volume":"56","author":"Unger","year":"1985","journal-title":"Circ. Res."},{"key":"10.1016\/j.npep.2007.09.003_bib48","first-page":"140","article-title":"Brain angiotensin: pathways and pharmacology.","volume":"77","author":"Unger","year":"1988","journal-title":"Circulation"},{"key":"10.1016\/j.npep.2007.09.003_bib49","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/sj.bjp.0705262","article-title":"Brain renin\u2013angiotensin system dysfunction in hypertension: recent advances and perspectives.","volume":"139","author":"Veerasingham","year":"2003","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.npep.2007.09.003_bib50","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00441-006-0190-8","article-title":"The CNS renin\u2013angiotensin system.","volume":"326","author":"von Bohlen und Halbach","year":"2006","journal-title":"Cell & Tissue Research"},{"key":"10.1016\/j.npep.2007.09.003_bib52","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/00004872-198412000-00009","article-title":"Endogenous opioids mediate sympathetic inhibition in response to a pressor stimulus in rabbits.","volume":"2","author":"Weinstock","year":"1984","journal-title":"J. of Hypertension"},{"key":"10.1016\/j.npep.2007.09.003_bib53","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/j.1440-1681.1986.tb00335.x","article-title":"The effect of naloxone on pressor responses to angiotensin II in anesthetized greyhounds.","volume":"13","author":"Wilkinson","year":"1986","journal-title":"Clin. & Exper. Pharmacol. & Physiol."},{"key":"10.1016\/j.npep.2007.09.003_bib54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1054\/npep.2000.0839","article-title":"Hippocampal administration of kappa-opioid receptor antisense exacerbates isolation-induced hypertension.","volume":"34","author":"Wright","year":"2000","journal-title":"Neuropeptides"},{"key":"10.1016\/j.npep.2007.09.003_bib55","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1210\/endo-125-2-785","article-title":"Effects of naloxone on vasopressin secretion in conscious rats: evidence of inhibitory role of endogenous opioid peptides in vasopressin secretion.","volume":"125","author":"Yamada","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/j.npep.2007.09.003_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0014-2999(82)90152-2","article-title":"Potency of three opiate antagonists to reverse the inhibitory activity of dynorphin, enkephalins and opioid-like alkaloids on the guinea pig ileum.","volume":"84","author":"Yoshimura","year":"1982","journal-title":"European Journal of Pharmacology"}],"container-title":["Neuropeptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417907000868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143417907000868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T04:08:53Z","timestamp":1557029333000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143417907000868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12]]},"references-count":54,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["S0143417907000868"],"URL":"https:\/\/doi.org\/10.1016\/j.npep.2007.09.003","relation":{},"ISSN":["0143-4179"],"issn-type":[{"value":"0143-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2007,12]]}}}